Literature DB >> 2649126

Chemotherapy for osteosarcoma.

R L Souhami1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2649126      PMCID： PMC2247015          DOI： 10.1038/bjc.1989.30

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  14 in total

Review 1.  Ifosfamide--pharmacology, safety and therapeutic potential.

Authors:  W P Brade; K Herdrich; M Varini
Journal:  Cancer Treat Rev       Date:  1985-03       Impact factor: 12.111

2.  Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?

Authors:  B Lange; A S Levine
Journal:  Cancer Treat Rep       Date:  1982-09

3.  Trends and variability in survival from osteosarcoma.

Authors:  W F Taylor; J C Ivins; D C Dahlin; J H Edmonson; D J Pritchard
Journal:  Mayo Clin Proc       Date:  1978-11       Impact factor: 7.616

4.  Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients.

Authors:  A M Goorin; M J Delorey; E E Lack; R D Gelber; K Price; J R Cassady; R Levey; D Tapper; N Jaffe; M Link
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

5.  Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

Authors:  G Rosen; B Caparros; A G Huvos; C Kosloff; A Nirenberg; A Cacavio; R C Marcove; J M Lane; B Mehta; C Urban
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

Review 6.  The role of methotrexate in osteosarcoma.

Authors:  J L Grem; S A King; R E Wittes; B Leyland-Jones
Journal:  J Natl Cancer Inst       Date:  1988-07-06       Impact factor: 13.506

7.  Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma.

Authors:  G Rosen; M Tefft; A Martinez; W Cham; M L Murphy
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

8.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

9.  Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.

Authors:  K Winkler; G Beron; R Kotz; M Salzer-Kuntschik; J Beck; W Beck; W Brandeis; W Ebell; R Erttmann; U Göbel
Journal:  J Clin Oncol       Date:  1984-06       Impact factor: 44.544

10.  Incidence of malignant disease in childhood: a 24-year review of the Manchester Children's Tumour Registry data.

Authors:  J M Birch; H B Marsden; R Swindell
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640
View more
  1 in total

1.  Sensitivity of rodent osteosarcoma clones to platinum-containing phosphonic acid complexes in vitro.

Authors:  T Klenner; P Valenzuela-Paz; B K Keppler; H R Scherf
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.